Ahmadipour N, Toth E, Law B J
Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON.
Direction de la protection de la santé publique, Ministère de la santé et des services sociaux du Québec, Québec, QC.
Can Commun Dis Rep. 2014 Dec 4;40(Suppl 3):37-40. doi: 10.14745/ccdr.v40is3a05.
The Vaccine Vigilance Working Group (VVWG) was created in 2004 as part of the National Immunization Strategy to strengthen vaccine safety in Canada. The Group has representation from all federal/provincial/territorial immunization programs across the country, as well as Health Canada regulators and the Immunization Monitoring Program ACTive (IMPACT) network. VVWG works to harmonize vaccine safety monitoring and adverse event reporting and management across Canada by developing and following national guidelines and seeking out best pharmacovigilance practices, including training. It also provides a national vaccine safety sentinel network that uses several mechanisms to rapidly share information on emerging safety issues to enable effective public health response. The "vigilance" in VVWG emphasizes the watchful, ever alert nature and activities of the Group's work. Increased public and health professional awareness of the VVWG's role and activities should help to allay concerns about vaccine safety that lead to vaccine hesitancy and in turn limit the effectiveness of immunization.
疫苗警戒工作组（VVWG）于2004年成立，作为国家免疫战略的一部分，旨在加强加拿大的疫苗安全性。该小组由加拿大全国所有联邦/省/地区免疫规划机构的代表组成，同时还有加拿大卫生部监管人员以及免疫监测项目ACT（IMPACT）网络的代表。疫苗警戒工作组通过制定和遵循国家指南并寻求最佳药物警戒实践（包括培训），努力协调加拿大全国的疫苗安全性监测以及不良事件报告与管理工作。它还提供了一个全国性疫苗安全哨兵网络，该网络利用多种机制迅速共享有关新出现安全问题的信息，以便能够做出有效的公共卫生应对。疫苗警戒工作组中的“警戒”强调了该小组工作始终保持警惕、时刻警觉的性质和活动。提高公众和卫生专业人员对疫苗警戒工作组作用和活动的认识，应有助于减轻导致疫苗犹豫并进而限制免疫效果的对疫苗安全性的担忧。
